Preparation of Powdered Fish Oil as a Sustained-Release Formulation

被引：0

作者：

Aoki, Shigeta ^{[1
]}

Nakagawa, Kiyotaka ^{[1
]}

Hanzawa, Yasuhiko ^{[1
]}

Matsumoto, Shunsuke ^{[2
]}

Akutsu, Mitsuaki ^{[2
]}

Kimizuka, Norihito ^{[3
]}

Shimoyamada, Makoto ^{[3
]}

Nishikawa, Masazumi ^{[3
]}

Miyazawa, Teruo ^{[1
,4
]}

机构：

[1] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan

[2] Aoba Kasei CO LTD, Izumi Ku, Sendai, Miyagi 9848642, Japan

[3] Miyagi Univ, Sch Food Agr & Environm Sci, Taihaku Ku, Sendai, Miyagi 9820215, Japan

[4] New Ind Creat Hatchery Ctr NICHe, Aoba Ku, Sendai, Miyagi 9808579, Japan

来源：

JOURNAL OF THE JAPANESE SOCIETY FOR FOOD SCIENCE AND TECHNOLOGY-NIPPON SHOKUHIN KAGAKU KOGAKU KAISHI | 2014年 / 61卷 / 10期

关键词：

powdered fish oil; DHA; EPA; slow-release property; X-RAY-DIFFRACTION; OXIDATIVE STABILITY; CARDIOVASCULAR-DISEASE; DOCOSAHEXAENOIC ACID; DROPLET SIZE; PALM STEARIN; FATTY-ACIDS; CRYSTALLIZATION; OMEGA-3-FATTY-ACIDS; ABSORPTION;

D O I：

10.3136/nskkk.61.467

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

Focusing on the gelatin/transglutaminase cross-linking reaction, we aimed to develop a preparation method for powdered fish oil as a sustained-release formulation. Various combinations of gelatin (containing transglutaminase) and emulsifiers were screened to obtain a high quality powder. The newly developed powder contained high amounts of lipids (74% of dry weight; 152 mg docosahexaenoic acid/g, 41 mg eicosapentaenoic acid/g); nevertheless, the powder exhibited good oxidation stability. As expected, the powdered fish oil showed slow-release properties in experiments in vitro. This novel powdered fish oil would therefore be useful for nutraceutical applications.

引用

页码：467 / 474

页数：8

共 50 条

[21] INVIVO EVALUATION OF A SUSTAINED-RELEASE FORMULATION OF RITODRINE
VANDERSCHOOT, JB
PHILIPS, WE
PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (05) : 227 - 227
[22] In Vitro Characterization of a Sustained-Release Formulation for Enfuvirtide
Rothstein, Sam N.
Huber, Kelly D.
Siuis-Cremer, Nicolas
Little, Steven R.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (03) : 1797 - 1799
[23] Formulation Optimization of Paliperidone Sustained-release Pellets
Zheng, Lin
Li, Li
Yin, Gang
Liao, Ronghui
Deng, Shengqi
Tao, Jing
Chinese Journal of Pharmaceuticals, 2023, 54 (02) : 224 - 229
[24] NEW SUSTAINED-RELEASE TABLET FORMULATION OF PROCAINAMIDE
FREMSTAD, D
DAHL, S
JACOBSEN, S
LUNDE, PKM
NADLAND, KJ
MARTHINSEN, AA
WAALER, T
LANDMARK, KH
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 6 (04) : 251 - 255
[25] THEORETICAL FORMULATION OF SUSTAINED-RELEASE DOSAGE FORMS
ROBINSON, JR
ERIKSEN, SP
JOURNAL OF PHARMACEUTICAL SCIENCES, 1966, 55 (11) : 1254 - &
[26] PHARMACOKINETICS OF A SUSTAINED-RELEASE PROCAINAMIDE PREPARATION
FLANAGAN, AD
ANGIOLOGY, 1982, 33 (02) : 71 - 77
[27] KINETICS OF A NALTREXONE SUSTAINED-RELEASE PREPARATION
CHIANG, CN
HOLLISTER, LE
KISHIMOTO, A
BARNETT, G
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) : 704 - 708
[28] UTILITY OF A SUSTAINED-RELEASE FORMULATION FOR ANTIHYPERTENSIVE THERAPY
SKAER, TL
SCLAR, DA
MARKOWSKI, DJ
WON, JKH
JOURNAL OF HUMAN HYPERTENSION, 1993, 7 (05) : 519 - 522
[29] FORMULATION AND EVALUATION OF SUSTAINED-RELEASE PARACETAMOL TABLETS
AHMED, M
ENEVER, RP
JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1981, 6 (01): : 27 - 38
[30] BIOAVAILABILITY OF METOCLOPRAMIDE FROM A SUSTAINED-RELEASE FORMULATION
BERNER, G
LEUSCHNER, F
WAGENER, HH
BECKER, A
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1984, 34-1 (05): : 637 - 639

← 1 2 3 4 5 →